Bacillus Calmette-Guerin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?

被引:1
|
作者
Tan, Wei Shen [1 ]
Grajales, Valentina [1 ]
Bree, Kelly [1 ]
Li, Roger [2 ]
Nogueras-Gonzalez, Graciela M. [3 ]
Navai, Neema [1 ]
Dinney, Colin [1 ]
Kamat, Ashish M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Urol, Tampa, FL USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
关键词
bacillus Calmette-Guerin; bladder cancer; bladder-sparing treatment; refractory; relapsing; outcomes;
D O I
10.1111/bju.16087
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:384 / 386
页数:3
相关论文
共 50 条
  • [31] PROGNOSTIC SIGNIFICANCE OF BACILLUS CALMETTE-GUERIN FAILURE CLASSIFICATION IN NON-MUSCLE-INVASIVE BLADDER CANCER REPLY
    Shirakawa, Hiroshi
    Kikuchi, Eiji
    BJU INTERNATIONAL, 2012, 110 (06) : E164 - E164
  • [32] Immune Predictors of Response after Bacillus Calmette-Guerin Treatment in Non-Muscle-Invasive Bladder Cancer
    Rodriguez-Izquierdo, Marta
    Del Canizo, Carmen G.
    Rubio, Carolina
    Reina, Ignacio A.
    Arroyo, Mario Hernandez
    Antolin, Alfredo Rodriguez
    Porto, Marta Duenas
    Guerrero-Ramos, Felix
    CANCERS, 2023, 15 (23)
  • [33] Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guerin (BCG) for Non-Muscle-Invasive Bladder Cancer
    Deng, Tuo
    Liu, Bing
    Duan, Xiaolu
    Zhang, Tao
    Cai, Chao
    Zeng, Guohua
    SCIENTIFIC REPORTS, 2017, 7
  • [34] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
  • [35] Re: Intravesical bacillus Calmette-Guerin with Interferon-Alpha versus Intravesical bacillus Calmette-Guerin for Treating Non-Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 608 - 609
  • [36] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [37] Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer: Its definition and future therapeutic strategies
    Kikuchi, Eiji
    Hayakawa, Nozomi
    Fukumoto, Keishiro
    Shigeta, Keisuke
    Matsumoto, Kazuhiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (02) : 108 - 116
  • [38] Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guerin Treatment in Non-muscle-invasive Bladder Cancer
    Tonyali, Senol
    Karaaslan, Mustafa
    Yilmaz, Mehmet
    Ceylan, Cavit
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2018, 17 (04): : 120 - 123
  • [39] Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin
    de Jong, Florus C.
    Laajala, Teemu D.
    Hoedemaeker, Robert F.
    Jordan, Kimberley R.
    van der Made, Angelique C. J.
    Boeve, Egbert R.
    van der Schoot, Deric K. E.
    Nieuwkamer, Bart
    Janssen, Emiel A. M.
    Mahmoudi, Tokameh
    Boormans, Joost L.
    Theodorescu, Dan
    Costello, James C.
    Zuiverloon, Tahlita C. M.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (697)
  • [40] Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin
    Packiam, Vignesh T.
    Johnson, Scott C.
    Steinberg, Gary D.
    CANCER, 2017, 123 (03) : 390 - 400